Overview
The BPC-157 / TB-500 blend combines two of the most studied tissue-repair associated research peptides. BPC-157 (Body Protective Compound 157) is a pentadecapeptide sequence derived from human gastric juice, studied extensively for its effects on tissue healing in various cell and animal models. TB-500 (Thymosin Beta-4 fragment) is an actin-binding peptide that plays roles in cell migration, angiogenesis, and inflammation modulation in research settings.
Nova Biolabs supplies this blend as a lyophilised vial from UK domestic stock, HPLC-verified at >98% purity.
Key Research Areas
Tissue Healing Research
BPC-157 and TB-500 have both been independently studied for their effects on tissue healing in various in vitro and in vivo models, making their combination a natural focus for regenerative research.
Angiogenesis Studies
TB-500 has been studied for its pro-angiogenic effects, including interaction with VEGF signalling pathways and endothelial cell migration — frequently studied in wound healing models.
Gastrointestinal Biology Research
BPC-157's gastric origin has made it a subject of research in gastrointestinal mucosal models, studying mucosal protection and repair signalling.
Musculoskeletal Cell Research
Both peptides have been studied in tendon, muscle, and connective tissue cell models for their effects on repair-associated signalling pathways.
Product Specifications
| Format | Lyophilised powder blend |
| Quantity | Blended 10mg vial (BPC-157 + TB-500) |
| Purity | >98% (HPLC verified) |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Origin | UK domestic stock |
| Research use | In vitro / laboratory use only |